Ameritas Investment Partners’s NantHealth, Inc NH Stock Holding History

Ameritas Investment Partners’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-159	Closed	-$2K	–	3342
2022 Q1	$2K	Hold	159	–	–	﹤0.01%	3058
2021 Q4	$3K	Hold	159	–	–	﹤0.01%	3089
2021 Q3	$4K	Hold	159	–	–	﹤0.01%	3058
2021 Q2	$6K	Hold	159	–	–	﹤0.01%	2992
2021 Q1	$8K	Hold	159	–	–	﹤0.01%	2936
2020 Q4	$8K	Hold	159	–	–	﹤0.01%	2898
2020 Q3	$6K	Hold	159	–	–	﹤0.01%	2950
2020 Q2	$11K	Buy	+159	New	+$6.34K	﹤0.01%	2693
2019 Q2	–	Sell	-37	Closed	-$1K	–	3141
2019 Q1	$1K	Hold	37	–	–	﹤0.01%	2969
2018 Q4	$0	Hold	37	–	–	﹤0.01%	3006
2018 Q3	$1K	Hold	37	–	–	﹤0.01%	3017
2018 Q2	$2K	Hold	37	–	–	﹤0.01%	2990
2018 Q1	$2K	Hold	37	–	–	﹤0.01%	2936
2017 Q4	$2K	Hold	37	–	–	﹤0.01%	2938
2017 Q3	$1K	Hold	37	–	–	﹤0.01%	2985
2017 Q2	$2K	Hold	37	–	–	﹤0.01%	2987
2017 Q1	$3K	Buy	+37	New	+$4.12K	﹤0.01%	2910

Other funds holding NH

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HIC

Hartline Investment Corp Winnetka, Illinois $1.15B AUM 65.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Ameritas Investment Partners's NH Position: Q2 2022 in Review

Ameritas Investment Partners sold out of NantHealth, Inc (NH) in Q2 2022, closing a stake of 159 shares — an estimated $2K sold.

Ameritas Investment Partners first reported a position in NH in Q1 2017 and held it in 17 quarters. The position peaked at $11K in Q2 2020. 42 funds tracked by Wall St. Rank hold NH as of Q2 2022.

Ameritas Investment Partners reported no remaining NantHealth, Inc position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 159 NantHealth, Inc shares in Q2 2022, an estimated $2K.
Ameritas Investment Partners first reported a position in NantHealth, Inc in Q1 2017 and held it in 17 quarters.
Ameritas Investment Partners's NantHealth, Inc position peaked at $11K in Q2 2020.
42 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.